Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.150
-0.040 (-1.83%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pfizer (Ireland) Revenue
18.23M12.62M
Pfizer (Ireland) Revenue Growth
44.46%0.76%
Fiocruz (Brazil) Revenue
11.06M11.03M
Fiocruz (Brazil) Revenue Growth
0.28%6.06%
Chiesi (Italy) Revenue
22.51M29.33M
Chiesi (Italy) Revenue Growth
-23.25%67.66%
Total Revenue from Selling Goods
51.80M52.98M
Total Revenue from Selling Goods Growth
-2.23%31.08%
Revenue from License and R&D Services
942.00K418.00K
Revenue from License and R&D Services Growth
125.36%-98.33%
Updated Mar 18, 2026. Data Source: Fiscal.ai.